Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 29, 2018 7:00 AM - Oct 29, 2018 5:30 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

Canadian Pharmacovigilance and Risk Management Strategies Conference

Session 5: Canada Vigilance Update

Session Chair(s)

Melissa  Hunt, MSc

Melissa Hunt, MSc


Health Canada, Canada

The Canada Vigilance Program is Health Canada's post-market surveillance program that collects and assesses reports of suspected adverse reactions to health products marketed in Canada. This session will focus on what is new within the Canada Vigilance program, developments around the Canada Vigilance database, and ongoing process improvements.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe the current state of the Canada Vigilance program
  • Explain future directions of the Canada Vigilance program
  • State current challenges and opportunities around the quality assurance of adverse reaction reports


Gayatri  Jayaraman, PhD, MPH

Canada Vigilance Program Update

Gayatri Jayaraman, PhD, MPH

Health Canada, Canada

Director, Marketed Health Products Directorate

Bill  Wilson

Canada Vigilance Program Update

Bill Wilson

Health Canada , Canada

A/Manager, Data Management and Integrity Section

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.